Objective: The aggressiveness of small adenocarcinomas has not been fully evaluated using integrated positron emission tomography/computed tomography (PET/CT). We investigated malignant aggressiveness according to PET/CT, high-resolution computed tomography (HR-CT) findings and the proportions of pathologically defined bronchioloalveolar carcinomas (BACs) in cT1N0M0 lung adenocarcinoma.
Introduction
Recent improvements in imaging technology and the widespread use of CT scans for screening have increased the probability of detecting small-sized lung cancers, especially adenocarcinomas, and this has led to concerns over whether some of these cancers can be sufficiently treated by sublobar resection as an alternative to lobectomy [1, 2] . In fact, about 20% of clinical T1 cancers have nodal involvement and the remainder follows a more indolent biological course. Since the risk of nodal involvement and subsequent systemic metastasis is not absolutely linked to tumor size [3] , the preoperative ability to distinguish biologically aggressive from indolent tumors is extremely important for an indication of sublobar resection.
On high-resolution computed tomography (HR-CT), Ground-glass opacity (GGO) defined as a misty component in lung attenuation, and tumor shadow disappearance rate (TDR) defined as the ratio of tumor area of the mediastinal window to that of the lung window, seem linked to adenocarcinoma aggressiveness and thus to the risk of nodal involvement [4, 5] . In addition, bronchioloalveolar carcinomas (BACs) typified by lepidic growth along alveoli without invasive areas are indolent and basically expressed as GGO or areas of tumor shadow disappearance on HR-CT.
On the other hand, integrated positron emission tomography-computed tomography with F-18 fluorodeoxyglucose (FDG-PET/CT), is a refined type of dedicated FDG-PET that measures a standardized uptake value (SUV). This is an increasingly useful noninvasive imaging modality with which to evaluate indeterminate lung nodules, regional lymph nodes, distant metastases, tumor invasiveness and responses to chemoradiotherapy [6] [7] [8] [9] [10] [11] [12] [13] [14] . Futhermore, FDG-PET/CT might be able to quantify the aggressiveness of small adenocarcinomas.
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Notably, preoperative imaging findings with PET/CT and HR-CT must be defined and correlated with pathological findings. Preoperatively understanding the biological features of small adenocarcinomas could provide clues to select patients for radical sublobar resection. We therefore examined correlations between SUV, GGO proportion and TDR with the BAC proportion defined on pathological sections of surgical specimens. The results of this study could improve approaches to diagnosing and treating small lung adenocarcinomas that might become a more vital part of thoracic surgical tradition.
Patients and Methods
Between October 2005 and September 2006, the same surgical team completely resected tumors and assessed ipsilateral hilar and mediastinal lymph nodes for primary cT1N0M0 lung adenocarcinomas (3 cm or less in diameter) in 60 consecutive patients. Our institutional review board approved the prospective database used in this retrospective analysis. Surgical-pathologic staging was performed according to the New International Staging System for Lung Cancer [15] .
All patients underwent integrated FDG-PET/CT and HR-CT within 1 month before resection.
Patients with diabetes were excluded from this study.
FDG-PET/CT scans were carried out on an integrated PET/CT scanner (Discovery ST8 PET/CT Scanner; General Electric, Milwaukee, Wis). Patients were requested to fast for 4 hours and then intravenously received 185 MBq (5 mCi) of FDG, followed by PET scanning after 40 minutes. Iterative reconstruction with CT attenuation correction was performed. Also, chest scan was available for visual correlation. Maximum SUV was established by drawing regions of interest on attenuation-corrected FDG-PET images around the primary tumor and calculated by the software within the PET/CT scanner using the following formula: Maximum SUV=[C(µCi/mL) / ID(µCi)] / w(kg), where C is defined as activity at a pixel within the tissue identified by an regions Okada et al. 6 PET/CT and HR-CT for biology of small adenocarcinoma of interest, and ID is defined as the injected dose per kilogram of the patient's body weight (w). We adopted maximum SUV in the present analysis because it is less variable than mean SUV in measuring [16] , and established a value of 2.5 g/mL or higher as positive.
Contrast-enhanced HR-CT was performed on a multi-detector CT capable of generating 16 x 0.5 mm slices (Aquilion 16SH; Toshiba Medical Systems, Tokyo, Japan). Slices with 1-mm spaces were taken through the tumor in addition to all slices with 6-mm spacing obtained from the apex of the lung to the base. The images were photographed using a window level of −600 Hounsfield units (HU) with a window width of 1700 HU (lung windows) and a level of 25 HU with a width of 350 HU (mediastinal windows). TDR and GGO were assessed by independent observers, and discrepancies in evaluation among them were resolved by averaging their determined values. The observers measured the maximum dimensions of the tumors (maxD) and the largest dimension perpendicular to the maximum axis (perD) on both the lung and mediastinal windows. As reported [4, 5, 17] , TDR was defined as follows:
TDR(%) =[1 -(maxD × perD on mediastinal windows / maxD × perD on lung windows)]×100
The tumors resected surgically were fixed in 10% formalin and embedded in paraffin. The sections including the largest cut were stained with hematoxylin-eosin and elastica van Gieson, for histopathological examination. The estimation regarding the proportion of BAC areas relative to the whole tumors was performed by independent pathologists in the same manner as that for PET/CT and HR-CT reviews. The clinical records of all patients were also reviewed to determine age, gender, smoking status, serum carcinoembryonic antigen (CEA) level, tumor size, operative procedure, lymph node status (N factor), lymphatic invasion (Ly factor), and vascular invasion (V factor). When lymphatic and blood vessels had been invaded, adenocarcinoma cells were histopathologically identifiable in the lymphatic and blood vessel lumen, respectively. Lymphatic and blood vessels were identified based on morphology using light microscopy and elastica stain.
Okada et al. 7 PET/CT and HR-CT for biology of small adenocarcinoma
Peritumoral invasion (observed outside the margin of the invasive carcinoma) and intratumoral types of invasion were assessed.
The associations between clinical factors and maximum SUV, GGO ratio, TDR and BAC ratio were evaluated using the χ 2 test, or the Fisher exact tests. To elucidate variables for the prediction of nodal, lymphatic and vessel involvement, we performed logistic regression analyses. To further clarify independent variables in relation to the prediction of nodal involvement, we performed multiple logistic regression analyses using gender for category and age, CEA, maximum SUV, GGO ratio, TDR and BAC ratio as continuous variables. We also examined which of maximum SUV, GGO ratio or TDR correlated more closely with the BAC ratio using a correlation coefficient.
Results
Of 60 patients examined, 31 (52%) were women and 29 were men. The mean age was 65 years (range 34-82 years). Thirty-one patients (52%) were smokers, of whom 17 currently smoked, and 29 had never smoked. Forty-eight patients (80%) had a normal preoperative CEA level, the upper limit of which was 5.0 ng/mL. Half of the patients had a primary tumor with a diameter of 20 mm or less and the other half had a tumor of 21 to 30 mm in diameter. Lobectomy was the most frequently applied type of resection (n=44, 73%) and 16 patients underwent segmental resections.
The reasons for sublobar resection included radical segmentectomy for tumors 2 cm or smaller in 11 patients and compromised reserve in 5. Pneumonectomy was never performed and wedge resection was excluded because nodal status could not be histopathologically confirmed. All patients had curative R0 resections. Lymphatic and vascular invasion occurred in 18 (30%) and 13 (22%) patients, respectively. Fifty-two patients (87%) had no nodal involvement, whereas hilar or mediastinal lymph node involvement was found in 8 patients (13%).
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The clinical features of the patients in relationship to maximum SUV on PET/CT are summarized in Table 1 . Larger tumors (p=0.0061) and a high preoperative CEA value (p=0.0169) were more frequent in patients with a positive maximum SUV. Maximum SUV did not differ with age, gender, smoking status and operative procedure. The CEA value was frequently high in patients whose proportions of GGO and TDR on HR-CT and pathological BAC on surgical specimen ( Table 2 ,3 and 4) were below 50% proportion (p=0.0446, p=0.0498 and p=0.0253, respectively).
We then analyzed the predictors for lymphatic invasion, vascular invasion and nodal metastasis (Table 5) . Maximum SUV, GGO proportion, TDR and BAC proportion were all found to be significant predictors of lymphatic (p<0.0001, p=0.0189, p=0.0020 and p=0.0005, respectively) and vascular (p<0.0001, p=0.0433, p=0.0256 and p<0.0001, respectively) invasion. Whereas maximum SUV, TDR and BAC proportion were significant predictors of nodal metastasis (p=0.0019, p=0.0201 and p=0.0053, respectively), the GGO proportion was not significantly useful for predicting nodal status (p=0.2487). Overall, maximum SUV, BAC ratio, TDR, and the GGO ratio in that order can likely reflect tumor aggressiveness. A multivariate analysis to determine independent predictors of pathologic nodal status (Table 6 ) revealed that none of age, gender and CEA were significant in any model. Maximum SUV (p=0.0199), TDR (p=0.0136) and BAC ratio(p=0.0375) were significantly useful predictors of nodal status although GGO ratio and nodal status correlated marginally but not significantly p=0.0800).
Last, we performed logistic regression analyses to clarify which radiographic parameter of maximum SUV, GGO ratio or TDR correlated better with a pathologic BAC ratio (Figure 1 ).
Although a significant correlation was found between BAC ratio versus maximum SUV, GGO ratio and TDR (all p<0.0001), maximum SUV (R 2 = 0.245) had a poorer association with BAC ratio compared with GGO ratio (R 2 = 0.554) and TDR (R 2 = 0.671). These data demonstrated that both TDR and GGO ratio on HR-CT were well correlated with pathologic BAC ratio and that
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maximum SUV on PET/CT had a much less impact as a preoperative indictor of pathologic BAC proportion.
Discussion
Although the proportion of the BAC component can mirror the malignant grade of small adenocarcinoma [4, 18, 19] , it is defined on post-surgical specimens. Since the parts indicating GGO or TDR on HR-CT seemed to closely correlate with BAC area, the proportion of GGO and TDR might be linked to tumor aggressiveness and subsequently to risk for nodal metastases and survival [4, 5, 17] . Characterizing and quantifying these findings on HR-CT, especially GGO, have been relatively subjective, since inter-observer discrepancies might have affected visual estimations.
Cerfolio and colleagues have reported that maximum SUV of a non-small cell lung cancer nodule on dedicated PET is an independent predictor of tumor characteristics for stage, recurrence and survival [11] . However, the utility of FDG-PET/CT in predicting the biological features of small adenocarcinomas, especially BACs remains obscure. While approximately 85% of non-small cell lung cancers are FDG positive, roughly 50% of adenocarcinomas with a BAC component are FDG positive and pure BAC is more likely to escape detection with FDG-PET [20, 21] . Lower metabolic activity in adenocarcinomas containing a BAC component is assumed to be secondary to the slower pace of BAC proliferation compared with other adenocarcinomas. If higher metabolic activity is linked to more tumor aggressiveness, FDG avidity (maximum SUV) might identify a group of adenocarcinomas that is more likely to have high-grade malignant behavior.
In the present series, adenocarcinoma with a high maximum SUV as well as a low percentage of GGO, TDR or BAC was more frequently associated with an increase in the serum CEA level.
Pre-surgical serum CEA values are important in identifying patients at high risk of potential Okada et al. 10 PET/CT and HR-CT for biology of small adenocarcinoma advanced disease and poor survival, and whose specificity is higher for adenocarcinoma than squamous cell carcinoma [22, 23] . The present study also uncovered an even closer relationship between maximum SUV and lymphatic, blood vessel and lymph node involvement compared with GGO, TDR and BAC. Surprisingly, maximum SUV obtained preoperatively could be a more reliable indicator for predicting tumor malignancy than BAC proportion obtained postoperatively.
These results suggested that maximum SUV is a reasonable surrogate marker of adenocarcinoma invasiveness and that FDG-PET/CT could be a powerful prognostic tool with which to identify patients at high and low risk of recurrence after complete resection of small adenocarcinomas with or without a BAC component.
The relationships between the pathological BAC ratio and radiographic maximum SUV, GGO ratio and TDR in small adenocarcinomas are of interest in helping to understand the fundamental role of maximum SUV. The extent of both the GGO area and TDR closely correlated with that of BAC growth. We however emphasize that maximum SUV, in comparison with the GGO ratio and TDR, was less associated with the BAC proportion. This discrepancy can be essential when considering the underlying significance of maximum SUV. That is, graphic maximum SUV unlike the GGO ratio or TDR is less able to reflect the pathological BAC proportion, and might be an imperative predictor for the grade of tumor malignancy independently of the BAC component.
The current relative decrease in the size of resected lung tumors allows a choice of various surgical options [2] . Choosing radical sublobar resection for patients that could tolerate lobectomy requires better methods of preoperatively distinguishing early indolent, from advanced aggressive cancers. However, no absolutely accurate preoperative indicators of tumor behavior have been defined although several studies have reported that the GGO ratio and TDR on HR-CT as well as tumor size and histology are useful [3] [4] [5] 17] . Our series showed that maximum SUV on PET/CT is a potentially promising parameter for determining an indication for radical sublobar resection. We also examined the relationship between maximum SUV and tumor size in Okada et al. 11 PET/CT and HR-CT for biology of small adenocarcinoma cT1N0M0 adenocarcinomas (Fig. 2) . We found that the larger the tumor, the higher was the maximum SUV, and both of these factors can predict tumor invasiveness and nodal metastases.
Thus, FDG-PET/CT in addition to HR-CT might be significantly useful for an indication of radical sublobar resection and a reduction in nodal dissection for surgically treating small adenocarcinomas, which requires further confirmation in a large cohort. SUV, standardized uptake value; FDG-PET/CT, positron emission tomography-computed tomography with F-18 fluorodeoxyglucose; SD, standard deviation; CEA, carcinoembryonic antigen. GGO, ground-glass opacity; HR-CT, high-resolution computed tomography; SD, standard deviation; CEA, carcinoembryonic antigen. 
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